SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (3116)3/27/1998 12:26:00 PM
From: Jacques Chitte  Read Replies (2) of 7041
 
What it means for ZONA is that they cannot be first to market!
Being second to market is only a viable option if the second drug has clear benefits. I have heard of many a good, promising compound that got the axe because someone else came up with something comparable first. If Zonagen persists, I expect to see SGP's sponsorship decline. Unless they have a Somethingelsemax nobody's talking about!
ZONA's stock price might whipsaw. Traders can have real fun here, and MMs demonstrably are laughing all the way to the bank. But I see the trend as Down. Individual fundamental investors: I applaud your loyalty to Zonagen, but I humbly recommend an immediate review of your premises! (Unless there's a Somethingelsemax in the wings.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext